Gregory W. Schafer, a member of the Board of Directors of Capricor Therapeutics, Inc., has notified the company that he will not stand for re-election when his term on the Board expires at the company's 2016 Annual Meeting of Stockholders, which is scheduled for June 2, 2016. Mr. Schafer will continue to serve as a member of the Board, as the Chairman of the Audit Committee of the Board and as a member of the Nominating and Corporate Governance Committee of the Board until the Annual Meeting. Mr. Schafer's decision not to stand for re-election is not due to any disagreement with the Company on any of the Company's operations, policies or practices.